Skip to content
healthcare.dev

Lacosamide

NDC 46708-174, lacosamide, tablet, film coated, from Alembic Pharmaceuticals Limited.

Product NDC
46708-174
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204974
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE200 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
46708-174-1046708017410100 TABLET, FILM COATED in 1 CARTON (46708-174-10)
46708-174-304670801743030 TABLET, FILM COATED in 1 BOTTLE (46708-174-30)
46708-174-604670801746060 TABLET, FILM COATED in 1 BOTTLE (46708-174-60)
46708-174-7146708017471500 TABLET, FILM COATED in 1 BOTTLE (46708-174-71)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/46b98d5e-fdb6-483a-b022-8b1f0aa832c5

Use it

Look up 46708-174 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.